Apyx Medical Corporation (APYX) financial statements (2020 and earlier)

Company profile

Business Address 5115 ULMERTON ROAD
CLEARWATER, FL 33760
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments597810141268
Cash and cash equivalents591610141268
Short-term investments 62     
Receivables9555322
Inventory, net of allowances, customer advances and progress billings5576668
Inventory5576668
Deposits current assets     01
Other undisclosed current assets4111121
Total current assets:77902327221520
Noncurrent Assets
Finance lease, right-of-use asset1
Operating lease, right-of-use asset0
Property, plant and equipment7666777
Intangible assets, net (including goodwill) 022201
Goodwill 0000  
Intangible assets, net (excluding goodwill) 022201
Deposits noncurrent assets 000000
Other noncurrent assets0000001
Other undisclosed noncurrent assets    025
Total noncurrent assets:86899913
TOTAL ASSETS:85963135312533
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12545432
Accounts payable2122121
Accrued liabilities9323221
Employee-related liabilities 1111  
Debt0 00000
Due to related parties0      
Other undisclosed current liabilities 21  01
Total current liabilities:12865443
Noncurrent Liabilities
Long-term debt and lease obligation1023333
Long-term debt, excluding current maturities 023333
Finance lease, liability0
Operating lease, liability0
Liabilities, other than long-term debt1 0000 
Deferred revenue and credits 000 
Other liabilities1      
Derivative instruments and hedges, liabilities  00   
Other undisclosed noncurrent liabilities  111136
Total noncurrent liabilities:10344169
Total liabilities:1389982012
Stockholders' equity
Stockholders' equity attributable to parent, including:7188222623219
Preferred stock   0   
Common stock0000000
Additional paid in capital57525050432929
Retained earnings (accumulated deficit)1536(28)(23)(19)(28)(10)
Other undisclosed stockholders' equity attributable to parent    0  
Other undisclosed stockholders' equity     32
Total stockholders' equity:7188222623521
TOTAL LIABILITIES AND EQUITY:85963135312533

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues28173937302824
Revenue, net173937302824
Cost of revenue
(Cost of Goods and Services Sold)
(9)(6)(19)(19)(17)(19)(14)
Gross profit:191120181399
Operating expenses(40)(24)(25)(22)(20)(23)(21)
Other operating expense, net (0)     
Other undisclosed operating income 0   88
Operating loss:(21)(14)(5)(4)(7)(6)(4)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
100(0)2(7)(2)
Interest and debt expense(0)(0)     
Loss from continuing operations before equity method investments, income taxes:(20)(13)(5)(4)(5)(13)(6)
Other undisclosed income from continuing operations before income taxes00     
Loss from continuing operations before income taxes:(20)(13)(5)(4)(5)(13)(6)
Income tax expense (benefit)040(0)(0)(4)(2)
Net loss:(20)(9)(5)(4)(5)(17)(8)
Other undisclosed net income attributable to parent      3
Net loss attributable to parent:(20)(9)(5)(4)(5)(17)(4)
Other undisclosed net income (loss) available to common stockholders, basic 74  14(1) 
Net income (loss) available to common stockholders, basic:(20)64(5)(4)8(18)(4)
Convertible preferred dividends    11,061 
Other undisclosed net loss available to common stockholders, diluted  (0)(0)(3)  
Net income (loss) available to common stockholders, diluted:(20)64(5)(4)71,042(4)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(20)(9)(5)(4)(5)(17)(8)
Comprehensive loss, net of tax, attributable to parent:(20)(9)(5)(4)(5)(17)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: